These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33102580)

  • 21. Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study.
    Etminan M; Aminzadeh K; Matthew IR; Brophy JM
    J Rheumatol; 2008 Apr; 35(4):691-5. PubMed ID: 18203310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials.
    Vaysbrot EE; Osani MC; Musetti MC; McAlindon TE; Bannuru RR
    Osteoarthritis Cartilage; 2018 Feb; 26(2):154-164. PubMed ID: 29222056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
    Loke YK; Jeevanantham V; Singh S
    Drug Saf; 2009; 32(3):219-28. PubMed ID: 19338379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
    Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
    Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
    Mauri D; Valachis A; Polyzos NP; Tsali L; Mavroudis D; Georgoulias V; Casazza G
    J Natl Compr Canc Netw; 2010 Mar; 8(3):279-86. PubMed ID: 20202461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials.
    Dömötör ZR; Vörhendi N; Hanák L; Hegyi P; Kiss S; Csiki E; Szakó L; Párniczky A; Erőss B
    Front Endocrinol (Lausanne); 2020; 11():573976. PubMed ID: 33240217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates and risk of atrial fibrillation: a meta-analysis.
    Kim SY; Kim MJ; Cadarette SM; Solomon DH
    Arthritis Res Ther; 2010; 12(1):R30. PubMed ID: 20170505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis.
    Mauri D; Valachis A; Polyzos IP; Polyzos NP; Kamposioras K; Pesce LL
    Breast Cancer Res Treat; 2009 Aug; 116(3):433-9. PubMed ID: 19521766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.
    Wright E; Schofield PT; Molokhia M
    BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis.
    Lopez-Olivo MA; Shah NA; Pratt G; Risser JM; Symanski E; Suarez-Almazor ME
    Support Care Cancer; 2012 Nov; 20(11):2985-98. PubMed ID: 22956190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates in multiple myeloma.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2010 Mar; (3):CD003188. PubMed ID: 20238320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinical Benefits of Antiresorptive Agents in Patients with Primary Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysis.
    Wang SF; Lin YS; Yeh WY; Chang YL; Chiang CE; Chen CH; Tseng LM; Lee HC; Liu CY; Cheng HM
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1433-e1447. PubMed ID: 37170778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity.
    Kharazmi M; Persson U; Warfvinge G
    J Oral Maxillofac Surg; 2012 Dec; 70(12):2793-7. PubMed ID: 22609135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysis.
    Valachis A; Polyzos NP; Georgoulias V; Mavroudis D; Mauri D
    Gynecol Oncol; 2010 Apr; 117(1):139-45. PubMed ID: 20061004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC
    JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis.
    Yang YL; Xiang ZJ; Yang JH; Wang WJ; Xiang RL
    Ther Adv Med Oncol; 2019; 11():1758835919855235. PubMed ID: 31217825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis.
    Yang G; Hu H; Zeng R; Huang J
    J Clin Gastroenterol; 2013 Oct; 47(9):741-8. PubMed ID: 24030705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.